Grossman William
Insider CIK 1730229 · BLCM Sr. VP, Chief Medical Officer · RCUS Chief Medical Officer · DAWN Director · ENGN Interim Chief Medical Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENGN enGene Therapeutics Inc. | P Buy | 2026-09-22 | 2026-09-24 | 5,102 | $1.97 | $10.1K | 5,102 | SEC↗ |
| ENGN enGene Therapeutics Inc. | P Buy | 2026-09-22 | 2026-09-24 | 5,102 | $1.97 | $10.1K | 5,102 | SEC↗ |
| ENGN enGene Therapeutics Inc. | A Award deriv | 2026-06-16 | 2026-06-17 | 31,000 | — | $0 | 31,000 | SEC↗ |
| ENGN enGene Therapeutics Inc. | A Award deriv | 2026-06-16 | 2026-06-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 22,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 15,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 66,660 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 66,660 | — | $0 | 66,660 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 32,335 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 66,660 | — | $0 | 0 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2025-07-08 | 2025-07-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-05-23 | 2024-05-28 | 32,335 | — | $0 | 32,335 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-01-17 | 2024-01-19 | 66,660 | — | $0 | 66,660 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-06-17 | 2021-06-21 | 3,891 | $23.68 | $92.1K | 20,723 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-06-16 | 2021-06-21 | 127 | $24.77 | $3.1K | 24,614 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-06-16 | 2021-06-21 | 3,047 | $24.13 | $73.5K | 24,741 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-04-23 | 2021-04-26 | 4,133 | $31.37 | $129.7K | 6,717 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-03-16 | 2021-03-18 | 2,127 | $35.03 | $74.5K | 10,850 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2021-01-19 | 2021-01-20 | 112,500 | — | $0 | 112,500 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2021-01-19 | 2021-01-20 | 18,750 | — | $0 | 25,477 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2020-12-16 | 2020-12-18 | 2,117 | $31.35 | $66.4K | 6,727 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2020-10-02 | 2020-10-05 | 100,000 | $17.00 | $1.70M | 100,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2020-10-02 | 2020-10-05 | 100,000 | — | $0 | 100,600 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2020-07-31 | 2020-08-04 | 100 | $19.77 | $2.0K | 500 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2020-07-31 | 2020-08-04 | 100 | $19.68 | $2.0K | 600 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2020-06-04 | 2020-06-08 | 55,000 | — | $0 | 55,400 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2020-01-17 | 2020-01-22 | 140,000 | — | $0 | 140,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-10-14 | 2019-10-15 | 300 | $8.00 | $2.4K | 400 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-10-10 | 2019-10-15 | 100 | $8.00 | $800 | 100 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2019-04-29 | 2019-05-01 | 400,000 | — | $0 | 400,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | F Tax w/h | 2019-02-05 | 2019-02-07 | 3,126 | $3.48 | $10.9K | 26,874 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-02-01 | 2019-02-05 | 82,500 | — | $0 | 82,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-02-05 | 2018-02-07 | 175,000 | — | $0 | 175,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award | 2018-02-05 | 2018-02-07 | 30,000 | — | $0 | 30,000 | SEC↗ |